Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015464
Filing Date
2023-05-04
Accepted
2023-05-04 07:52:31
Documents
85
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20230331.htm   iXBRL 10-Q 1372610
2 EX-31.1 lnth10q-033123ex311.htm EX-31.1 11764
3 EX-31.2 lnth10q-033123ex312.htm EX-31.2 11664
4 EX-32.1 lnth10q-033123ex321.htm EX-32.1 9838
  Complete submission text file 0001628280-23-015464.txt   7101845

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20230331.xsd EX-101.SCH 53093
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20230331_cal.xml EX-101.CAL 87572
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20230331_def.xml EX-101.DEF 191274
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20230331_lab.xml EX-101.LAB 609402
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20230331_pre.xml EX-101.PRE 384063
79 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20230331_htm.xml XML 1238657
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 23886581
SIC: 2835 In Vitro & In Vivo Diagnostic Substances